Myriam Loyo Li, M.D. (2018)
Myriam Loyo Li, M.D., assistant professor of otolaryngology/head and neck surgery in the OHSU School of Medicine and part of the newly created OHSU Facial Nerve Center. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
Two syringes with the gene therapy treatment Luxturna lie on a table in the surgery suite during Caspian Soto's surgery. Soto, 4, is among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
Surgeons Andreas Lauer, M.D., (left) and Steven Bailey, M.D., (at scope) operate on Caspian Soto, 4, one of the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
Surgeons Andreas Lauer, M.D., (left) and Steven Bailey, M.D., operate on Caspian Soto, 4, among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
The Luxturna treatment is injected into Caspian Soto's eye. Soto is among first in Oregon to have new treatment for rare, blindness-causing genetic mutation, September 17, 2018 at the OHSU Casey Eye Institute in Portland, Oregon. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
Surgeons operate on Caspian Soto, 4, who is among the first in Oregon to have new treatment for rare, blindness-causing genetic mutation, September 17, 2018 at the OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)
Luxturna gene therapy
Dr. Paul Yang talks with Krista Soto and her husband Zack about their son Caspian's eye condition as Caspian holds a yo-yo close to his face to see it better, during an exam at the OHSU Casey Eye Institute, July 25, 2018 in Portland, Oregon. Caspian,4, is among first in Oregon to have new treatment for rare, blindness-causing genetic mutation. (OHSU/Kristyna Wentz-Graff)
OHSU Doernbecher Children's Hospital therapy dogs
OHSU Doernbecher Children's Hospital therapy dog, Davis, visits with Connor Zimmerman, 8, in September, 2018. Doernbecher is the only hospital in the Northwest and among the few in the U.S. with two hospital therapy dogs, who can help make the hospital feel less frightening. (OHSU/Kristyna Wentz-Graff)
